Report cover image

Global & Slovakia Cancer Therapeutics Market to 2031

Published Jun 04, 2025
Length 100 Pages
SKU # BMKS20063503

Description

Cancer ranks as the second leading cause of death in Slovakia. Smoking remains a significant risk factor, with 21% of the population smoking daily—higher than the European average of 18%. Additionally, Slovakia’s annual per capita alcohol consumption stands at 10 liters, exceeding the average across the European Union. Cancer screening rates are also below optimal levels; in 2023-2024, only about 25% of the eligible population underwent breast cancer screening, compared to 54% in typical European countries.

Tackling these issues requires a comprehensive approach focused on early detection and prevention, which in turn calls for increased investment in the country’s healthcare infrastructure. To reduce disparities in treatment access and alleviate the socioeconomic impact of cancer, the OnkoAlliance Slovakia and the European Cancer Organisation partnered with Slovakia’s Ministry of Health in 2023 to launch the “Cancer Screening from Policy to Implementation” campaign. This government-led initiative, combined with rising awareness about cancer, is expected to drive increased demand for cancer therapeutics throughout the forecast period.

Table of Contents

100 Pages
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Data Triangulation and Validation:
4. Slovakia Cancer Therapeutics Market Landscape
4.1 Overview
4.2 Ecosystem Analysis
4.2.1 List of Vendors in the Value Chain
5. Cancer Therapeutics Market Key Market Dynamics
5.1 Cancer Therapeutics Market – Key Market Dynamics
5.2 Market Drivers
5.3 Market Restraints
5.4 Market Opportunities
5.5 Future Trends
5.6 Impact of Drivers and Restraints
6. Slovakia Cancer Therapeutics Market – Analysis
6.1 Slovakia Cancer Therapeutics Market Revenue (US$ Million), 2021–2031
6.2 Slovakia Cancer Therapeutics Market Revenue and Forecast Analysis
7. Slovakia Cancer Therapeutics Market Analysis – by Therapy Types
7.1 Slovakia Cancer Therapeutics Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Therapy Types
8. Slovakia Cancer Therapeutics Market Analysis – by Indications
8.1 Slovakia Cancer Therapeutics Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Indications
9. Slovakia Cancer Therapeutics Market Analysis – by Distribution Channel
9.1 Slovakia Cancer Therapeutics Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Distribution Channel
10. Competitive Landscape
10.1 Heat Map Analysis by Key Players
10.1 Company Positioning and Concentration
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.2 Partnerships and Collaborations
11.2 Other Developments
12. Company Profiles
12.1 Bristol-Myers Squibb Co
12.1. 1 Key Facts
12.1. 2 Business Description
12.1. 3 Products and Services
12.1. 4 Financial Overview
12.1. 5 SWOT Analysis
12.1. 6 Key Developments
12.2 AbbVie Inc
12.2. 1 Key Facts
12.2. 2 Business Description
12.2. 3 Products and Services
12.2. 4 Financial Overview
12.2. 5 SWOT Analysis
12.2. 6 Key Developments
12.3 Johnson & Johnson
12.3. 1 Key Facts
12.3. 2 Business Description
12.3. 3 Products and Services
12.3. 4 Financial Overview
12.3. 5 SWOT Analysis
12.3. 6 Key Developments
12.4 F. Hoffmann-La Roche Ltd
12.4. 1 Key Facts
12.4. 2 Business Description
12.4. 3 Products and Services
12.4. 4 Financial Overview
12.4. 5 SWOT Analysis
12.4. 6 Key Developments
12.5 Pfizer Inc
12.5. 1 Key Facts
12.5. 2 Business Description
12.5. 3 Products and Services
12.5. 4 Financial Overview
12.5. 5 SWOT Analysis
12.5. 6 Key Developments
12.6 AstraZeneca Plc
12.6. 1 Key Facts
12.6. 2 Business Description
12.6. 3 Products and Services
12.6. 4 Financial Overview
12.6. 5 SWOT Analysis
12.6. 6 Key Developments
12.7 Merck KGaA
12.7. 1 Key Facts
12.7. 2 Business Description
12.7. 3 Products and Services
12.7. 4 Financial Overview
12.7. 5 SWOT Analysis
12.7. 6 Key Developments
12.8 Novartis AG
12.8. 1 Key Facts
12.8. 2 Business Description
12.8. 3 Products and Services
12.8. 4 Financial Overview
12.8. 5 SWOT Analysis
12.8. 6 Key Developments
12.9 Astellas Pharma Inc
12.9. 1 Key Facts
12.9. 2 Business Description
12.9. 3 Products and Services
12.9. 4 Financial Overview
12.9. 5 SWOT Analysis
12.9. 6 Key Developments
12.10 Eli Lilly and Co
12.10. 1 Key Facts
12.10. 2 Business Description
12.10. 3 Products and Services
12.10. 4 Financial Overview
12.10. 5 SWOT Analysis
12.10. 6 Key Developments
13. Appendix
13.1 About Business Market Insights
13.2 List of Abbreviations
TABLE OF TABLES
Table 1. Slovakia Cancer Therapeutics Market Segmentation
Table 2. List of Vendors
Table 3. Slovakia Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million)
Table 4. Slovakia Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million)
Table 5. Slovakia Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million) – by Therapy Types
Table 6. Slovakia Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Therapy Types
Table 7. Slovakia Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million) – by Indications
Table 8. Slovakia Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications
Table 9. Slovakia Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million) – by Distribution Channel
Table 10. Slovakia Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Distribution Channel
Table 11. List of Abbreviations
TABLE OF FIGURES
Figure 1. Impact Analysis of Drivers and Restraints
Figure 2. Slovakia Cancer Therapeutics Market Revenue, (US$ Million), 2021–2031
Figure 3. Heat Map Analysis by Key Players
Figure 4. Company Positioning and Concentration

Search Inside Report

How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.